Načítá se...
6ER-024 Immune checkpont inhibitors in pharmacological therapy
BACKGROUND: The development of immunotherapy has proved to be a promising strategy in the treatment of cancer. The role of immune checkpoint inhibitors (ICIs) is highlighted. PURPOSE: To review the different ICIs available in clinical practice, analysing the authorised therapeutic indications and re...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535323/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.516 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|